Archit Organosys Ltd

BSE: 524640

20

total announcements

ARCHITORG.BO · 15 min delayed

Key Stats · Yahoo Finance · as of 16 Nov 2026

Market Cap

₹138 Cr

P/E (TTM)

18.4

EPS (TTM)

₹3.64

52W Low

₹34.00

52W High

₹72.00

Dividend Yield

1.48%

Beta

-0.06

Price / Book

1.7

Return on Equity

9.80%

Debt / Equity

9.6

Revenue (TTM)

₹176 Cr

Gross Margin

24.20%

Operating Margin

5.85%

BSEBoard MeetingResults4 Nov 2026

Archit Organosys Ltd

Outcome Of Board Meeting

Archit Organosys Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with revenue from operations at Rs. 6,399.46 lakhs and total income at Rs. 6,463.08 lakhs.

Read more →📎 1 attachment
BSEBoard MeetingResults29 Oct 2026

Archit Organosys Ltd

Archit Organosys Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve the unaudited financial result for the quarter and half year ended on 30th September, 2026

Archit Organosys Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 04/11/2026 to consider and approve the unaudited financial result for the quarter and half year ended on 30th September, 2026.

Read more →📎 1 attachment
BSECompany UpdateResults15 Oct 2026

Archit Organosys Ltd

Certificate under Regulation 74(5)

Archit Organosys Ltd has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities for the quarter ended September 30, 2026.

Read more →📎 1 attachment
BSEAGM/EGMResults2 Oct 2026

Archit Organosys Ltd

Voting result for 33rd Annual General Meeting

Archit Organosys Ltd has announced the voting results of its 33rd Annual General Meeting (AGM), where all resolutions were passed. The company received 100% votes in favor of the audited financial statement, and 99.9718% votes in favor of appointing a director in place of Shri Kandarp K. Amin.

Read more →📎 1 attachment
BSEAGM/EGMResults30 Sept 2026

Archit Organosys Ltd

Outcome of 33rd Annual general Meeting

Archit Organosys Ltd held its 33rd Annual General Meeting through Video Conferencing, where the company secretary informed about the remote e-voting facility and the combined result of e-voting will be announced within two working days. The meeting approved various resolutions, including the appointment of a director, declaration of dividend, and increase in loan limits.

Read more →📎 1 attachment
BSEGeneralcorrigendum24 Sept 2026

Archit Organosys Ltd

Corrigendum to the Annual Report for FY 2025-26

Archit Organosys Ltd has issued a corrigendum to its Annual Report for FY 2025-26, withdrawing agenda items 8, 9, and 10 related to authorized share capital increase, acquisition of shares, and preferential equity share issue.

Read more →📎 1 attachment
BSECorp. ActionDividend3 Sept 2026

Archit Organosys Ltd

Record date for purpose of Final Dividend

Archit Organosys Ltd has announced the record date for the purpose of final dividend for FY 2025-26, subject to approval of shareholders in the ensuing Annual General Meeting.

Read more →📎 1 attachment
BSECompany UpdateFundraise3 Sept 2026

Archit Organosys Ltd

Outcome of Board Meeting for Issue and allotment of Equity Shares on preferential Basis

Archit Organosys Ltd has announced the outcome of its board meeting, where it has approved the increase in authorized share capital from Rs. 25 crores to Rs. 60 crores and the issuance of up to 3.72 crore equity shares through a preferential issue for consideration other than cash, at an issue price of Rs. 65 per equity share.

Read more →📎 1 attachment
BSEBoard MeetingResults7 Aug 2026

Archit Organosys Ltd

Archit Organosys Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve the Unaudited Financial Results ....

Archit Organosys Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 to consider and approve the Unaudited Financial Results of the Company for the Quarter ended on June 30, 2026.

Read more →📎 1 attachment